Poly Medicure Ltd
NSE:POLYMED
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
1 390.55
3 128.9
|
Price Target |
|
We'll email you a reminder when the closing price reaches INR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one POLYMED stock under the Base Case scenario is 1 217.29 INR. Compared to the current market price of 2 582.15 INR, Poly Medicure Ltd is Overvalued by 53%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Poly Medicure Ltd
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for POLYMED cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Poly Medicure Ltd
Balance Sheet Decomposition
Poly Medicure Ltd
Current Assets | 19.2B |
Cash & Short-Term Investments | 12.6B |
Receivables | 3.3B |
Other Current Assets | 3.3B |
Non-Current Assets | 11.3B |
Long-Term Investments | 442.9m |
PP&E | 9.8B |
Intangibles | 551.4m |
Other Non-Current Assets | 495.8m |
Current Liabilities | 4.2B |
Accounts Payable | 1.5B |
Other Current Liabilities | 2.7B |
Non-Current Liabilities | 440.1m |
Long-Term Debt | 23.5m |
Other Non-Current Liabilities | 416.5m |
Earnings Waterfall
Poly Medicure Ltd
Revenue
|
15.2B
INR
|
Cost of Revenue
|
-5.1B
INR
|
Gross Profit
|
10.1B
INR
|
Operating Expenses
|
-6.8B
INR
|
Operating Income
|
3.3B
INR
|
Other Expenses
|
-382.6m
INR
|
Net Income
|
2.9B
INR
|
Free Cash Flow Analysis
Poly Medicure Ltd
INR | |
Free Cash Flow | INR |
In Q2 FY '25, Poly Medicure reported impressive revenue growth of 23%, on track to meet its 22-24% annual guidance. The operating EBITDA margin improved to 28%, up from 25.82% the previous year, demonstrating a margin target increase of 100-150 basis points for the full year. Significant growth was noted in the renal business, expected to reach INR 150 crores for FY '25. Export business thrived, logging a 35% growth, particularly in Europe. They aim for $2-$3 million in the U.S. this year, with a long-term target of $15-$20 million. The company continues investing in new plants to double its renal capacity, fortifying its growth trajectory.
What is Earnings Call?
POLYMED Profitability Score
Profitability Due Diligence
Poly Medicure Ltd's profitability score is 60/100. The higher the profitability score, the more profitable the company is.
Score
Poly Medicure Ltd's profitability score is 60/100. The higher the profitability score, the more profitable the company is.
POLYMED Solvency Score
Solvency Due Diligence
Poly Medicure Ltd's solvency score is 99/100. The higher the solvency score, the more solvent the company is.
Score
Poly Medicure Ltd's solvency score is 99/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
POLYMED Price Targets Summary
Poly Medicure Ltd
According to Wall Street analysts, the average 1-year price target for POLYMED is 2 394.71 INR with a low forecast of 2 050.3 INR and a high forecast of 2 992.5 INR.
Dividends
Current shareholder yield for POLYMED is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Ownership
POLYMED Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Poly Medicure Ltd. engages in the provision and sales of medical devices. The company is headquartered in Faridabad, Haryana. The company went IPO on 2011-12-05. The firm is primarily in the business of manufacture and sale of medical devices. The firm offers a diverse portfolio of medical devices in the product verticals of infusion therapy, oncology, anesthesia and respiratory care, urology, gastroenterology, blood management and blood collection, surgery and wound drainage, dialysis, central venous access catheters, veterinary medical devices, and others. The company supplies its products to approximately 110 countries, in Europe, Africa, Americas, Australia, and Asia. Its products include suction control valve, safety arterial cannula, VTM Kit, VLTM kit, blood collection needle with flashback, and pre-filled syringes. The firm operate eight manufacturing facilities across India, China, Egypt, and Italy. In India, it operates five manufacturing facilities, three of which are situated at Faridabad (Haryana), and one each in Jaipur (Rajasthan) and Haridwar (Uttarakhand).
Contact
IPO
Employees
Officers
The intrinsic value of one POLYMED stock under the Base Case scenario is 1 217.29 INR.
Compared to the current market price of 2 582.15 INR, Poly Medicure Ltd is Overvalued by 53%.